跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIZATAZ - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
BIZATAZ
Approved
STANDARD
BIZATAZ
Laboratorio Reig Jofre, S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f41fec319a6d238b
Company
Laboratorio Reig Jofre, S.A.
Type
Standard
Approval Details
Approval Id
f41fec319a6d238b
Drug Approval Philippines Name
BIZATAZ
Product Name
BIZATAZ
Registration Number
DRP-5865
Brand Name
BIZATAZ
Generic Name
PIPERACILLIN (AS SODIUM) + TAZOBACTAM (AS SODIUM)
Dosage Form
Powder For Injection (IM/IV)
Dosage Strength
2g/250mg
Manufacturer
Laboratorio Reig Jofre, S.A.
Importer
Penta Labs Australia (Philippines)
Distributor
JUSTRIGHT HEALTHCARE INC.
Issuance Date
25 March 2025
Expiry Date
06 April 2031
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f41fec319a6d238b
Type
Standard
Back to Philippines FDA Approvals